Prevention and Treatment of Disseminated Gonococcal Infection

Introduction to Prevention

The Centers for Disease Control and Prevention (CDC) emphasizes that condom use is crucial in preventing the transmission of sexually transmitted infections (STIs) including gonorrhea 1
Condoms provide a mechanical barrier that prevents direct contact with infectious secretions, and research has demonstrated that condom use is associated with statistically significant protection against several STIs, including gonorrhea 1
Condoms also protect against other STIs that may co-exist with gonorrhea, particularly chlamydia, which frequently co-occurs with gonococcal infections 2, 3

Comprehensive prevention includes partner notification and treatment, with all recent sexual partners being evaluated and treated to prevent reinfection 4
Risk-reduction counseling is important, with patients understanding the importance of knowing their partners' risk behaviors and avoiding high-risk partners 1
The CDC recommends consistent condom use as the most appropriate recommendation to prevent future recurrence of disseminated gonococcal infection in sexually active individuals 1

Hospitalization for initial therapy is recommended for patients with disseminated gonococcal infection (DGI) 4
Ceftriaxone 1g IV/IM every 24 hours is the first-line treatment for DGI 4
Treatment for presumptive chlamydial co-infection is necessary, as chlamydia frequently co-occurs with gonococcal infections 2, 3, 4
Partners should be treated even if asymptomatic to prevent reinfection 4